MedMira MMIRF Stock
MedMira Price Chart
MedMira MMIRF Financial and Trading Overview
| MedMira stock price | 0.01 USD |
| Previous Close | 0.01 USD |
| Open | 0.05 USD |
| Bid | 0.01 USD x 4000000 |
| Ask | 0.47 USD x 0 |
| Day's Range | 0.05 - 0.05 USD |
| 52 Week Range | 0.01 - 0.95 USD |
| Volume | 28K USD |
| Avg. Volume | 1.69K USD |
| Market Cap | 31.58M USD |
| Beta (5Y Monthly) | 0.749 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MMIRF Valuation Measures
| Enterprise Value | 25.78M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 167.52544 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 136.789 |
| Enterprise Value/EBITDA | -10.744 |
Trading Information
MedMira Stock Price History
| Beta (5Y Monthly) | 0.749 |
| 52-Week Change | -60.58% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.95 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.04 USD |
MMIRF Share Statistics
| Avg. Volume (3 month) | 1.69K USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 701.73M |
| Float | 209.72M |
| Short Ratio | N/A |
| % Held by Insiders | 65.54% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2025 |
| Most Recent Quarter (mrq) | January 31, 2026 |
| Next Fiscal Year End | July 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1653.055% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -39.11% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 188.5K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | -64.50% |
| Gross Profit (ttm) | -645017 USD |
| EBITDA | -2399914 USD |
| Net Income Avi to Common (ttm) | -3494626 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 96.2K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 17.39M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.065 |
| Book Value Per Share (mrq) | -0.024729254 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1960287 USD |
| Levered Free Cash Flow (ttm) | -684017 USD |
Profile of MedMira
| Country | United States |
| State | NS |
| City | Halifax |
| Address | 155 Chain Lake Drive |
| ZIP | B3S 1B3 |
| Phone | 902 450 1588 |
| Website | https://medmira.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Q&A For MedMira Stock
What is a current MMIRF stock price?
MedMira MMIRF stock price today per share is 0.01 USD.
How to purchase MedMira stock?
You can buy MMIRF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MedMira?
The stock symbol or ticker of MedMira is MMIRF.
Which industry does the MedMira company belong to?
The MedMira industry is Biotechnology.
How many shares does MedMira have in circulation?
The max supply of MedMira shares is 701.73M.
What is MedMira Price to Earnings Ratio (PE Ratio)?
MedMira PE Ratio is now.
What was MedMira earnings per share over the trailing 12 months (TTM)?
MedMira EPS is 0 USD over the trailing 12 months.
Which sector does the MedMira company belong to?
The MedMira sector is Healthcare.